Iron‐related MRI images in patients with pantothenate kinase–associated neurodegeneration (PKAN) treated with deferiprone: Results of a phase II pilot trial
Movement Disorders2011Vol. 26(9), pp. 1755–1759
Citations Over TimeTop 10% of 2011 papers
Giovanna Zorzi, Federica Zibordi, Luisa Chiapparini, Enrico Bertini, Lidia Russo, Antonio Piga, Filomena Longo, Barbara Garavaglia, Domenico Aquino, M. Savoiardo, Alessandra Solari, Nardo Nardocci
Abstract
Future trials assessing the clinical efficacy of chelating therapy should consider early symptomatic patients and a longer treatment period.
Related Papers
- → Combined therapy with deferiprone and desferrioxamine(1998)218 cited
- → Chelation of cobalt by combining deferasirox, deferiprone and desferrioxamine in rats(2014)9 cited
- → Efficacy of Deferiprone in the Treatment of Acute Iron Intoxication in Rats(1996)13 cited
- → Orally active iron chelators(2002)14 cited
- Effective new treatments of iron overload in thalassaemia using the ICOC combination therapy protocol of deferiprone (L1) and deferoxamine and of new chelating drugs.(2006)